Stoke Therapeutics Inc (STOK) — Financial Flexibility Index
Stoke Therapeutics Inc (STOK) has a Financial Flexibility Index of -1.13x as of June 2026. Free cash flow of $-54.61 Million (operating CF $-56.59 Million minus capex $1.98 Million) represents -1% of total liabilities ($48.42 Million). Check Stoke Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Stoke Therapeutics Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Stoke Therapeutics Inc across 9 annual periods. For the full cash flow conversion analysis, see Stoke Therapeutics Inc operating cash flow efficiency.
Annual Financial Flexibility Index for Stoke Therapeutics Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Stoke Therapeutics Inc. Explore Stoke Therapeutics Inc (STOK) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.70x | $46.26 Million | $45.59 Million | $65.98 Million | ▲ +134.4% |
| 2024 | -2.04x | $-86.65 Million | $-86.85 Million | $42.53 Million | ▼ -76.3% |
| 2023 | -1.16x | $-79.45 Million | $-81.07 Million | $68.78 Million | ▼ -194.8% |
| 2022 | -0.39x | $-27.90 Million | $-31.87 Million | $71.22 Million | ▲ +87.4% |
| 2021 | -3.12x | $-65.71 Million | $-66.91 Million | $21.09 Million | ▲ +10.3% |
| 2020 | -3.48x | $-41.17 Million | $-42.22 Million | $11.85 Million | ▲ +48.9% |
| 2019 | -6.81x | $-29.42 Million | $-31.05 Million | $4.32 Million | ▼ -67.7% |
| 2018 | -4.06x | $-10.03 Million | $-10.96 Million | $2.47 Million | ▼ -187.3% |
| 2017 | -1.41x | $-5.27 Million | $-5.38 Million | $3.73 Million | — |